Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Once again......

I believe that PTSC and with the help of TPL (some persuading / financial benefits) could have easily waited and announced multiples new licensees. Whether multiples signing would make a difference who knows.

It does not take too much imagination, especially for a company that has been working with millions to create much more interest if that was their goal.

PTSC personnels are professionals, they could easily solicit (pay)with the help of other professionals create any goals that PTSC has in mind, respective of their current situation to which we are not privy to.

Now here's the rub; what is PTSC as company really striving for in the short term?  Who benefits in the Short term? I believe short term shareholders are not what PTSC is overly concern with. But for the long term shareholder as has been stated by Pohl on several occasion will benefit the most, and  I am banking for the long term.

 If I had the money, and after tracking this stock for past few years, I would definetly play the short to keep it more interesting. I have the feeling many here probably have been doing that .

GLTA

Tom

 

 

Share
New Message
Please login to post a reply